Replimune Group logo

Replimune Group Share Price (NASDAQ: REPL)

$5.59

0.1

(1.82%)

Live

Last updated on

Check the interactive Replimune Group Stock chart to analyse performance

Replimune Group stock performance

as on August 27, 2025 at 1:29 AM IST

  • Today's Low:$5.46
    Today's High:$5.66

    Day's Volatility :3.45%

  • 52 Weeks Low:$2.68
    52 Weeks High:$17.00

    52 Weeks Volatility :84.24%

Replimune Group Stock Returns

PeriodReplimune Group IncS&P BSE IndustrialsNifty Smallcap 250
3 Months
-34.8%
-1.8%
2.7%
6 Months
-59.3%
18.6%
18.1%
1 Year
-46.65%
-9.3%
-5.6%
3 Years
-71.32%
127.4%
84.9%

Replimune Group Inc Key Stats

Check Replimune Group key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$5.49
Open
$5.46
Today's High
$5.72
Today's Low
$5.46
Market Capitalization
$428.5M
Today's Volume
$1.6M
52 Week High
$17.0
52 Week Low
$2.68
Revenue TTM
$0.0
EBITDA
$-287.2M
Earnings Per Share (EPS)
$-3.24
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-73.44%

Stock Returns calculator for Replimune Group Stock including INR - Dollar returns

The Replimune Group stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Replimune Group investment value today

Current value as on today

₹58,836

Returns

₹41,164

(-41.16%)

Returns from Replimune Group Stock

₹45,675 (-45.68%)

Dollar Returns*

₹4,511 (+4.51%)

Indian investors sentiment towards Replimune Group Stock

-15.45%

Period: Jul 26, 2025 to Aug 25, 2025. Change in 30 Days versus previous period

Investment in Replimune Group Shares from India has dropped by -15.45% over the past 30 days, indicating reduced transactional activity.

1%

Period: Jul 26, 2025 to Aug 25, 2025. Change in 30 Days versus previous period

Search interest for Replimune Group Stock from India on INDmoney has increased by 1% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Replimune Group Inc

  • Name

    Holdings %

  • Baker Bros Advisors LP

    14.20%

  • T. Rowe Price Associates, Inc.

    13.91%

  • BlackRock Inc

    7.79%

  • Redmile Group, LLC

    6.00%

  • FCPM III SERVICES BV

    5.02%

  • Vanguard Group Inc

    4.46%

Analyst Recommendation on Replimune Group Stock

Rating
Trend

Buy

    93%Buy

    6%Hold

    0%Sell

Based on 15 Wall street analysts offering stock ratings for Replimune Group(by analysts ranked 0 to 5 stars)

Replimune Group Share Price Target

What analysts predicted

Downside of 13.11%

Target:

$4.86

Current:

$5.59

Replimune Group share price target is $4.86, a slight Downside of 13.11% compared to current price of $5.59 as per analysts' prediction.

Replimune Group Stock Insights

  • Price Movement

    In the last 7 days, REPL stock has moved up by 6.7%
  • Price Movement

    In the last 1 month, REPL stock has moved up by 74.3%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 37.13 Cr → 20.08 Cr (in ₹), with an average decrease of 45.9% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 1.73 Cr → 2.49 Cr (in ₹), with an average increase of 30.5% per quarter
  • REPL vs One 97 Communications Ltd (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 64.8% return, outperforming this stock by 111.4%
  • REPL vs One 97 Communications Ltd (1 yr)

    In the last 1 year, One 97 Communications Ltd has given 140.6% return, outperforming this stock by 153.6%
  • REPL vs Firstsource Solutions Ltd (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 110.3% return, outperforming this stock by 181.7%
  • REPL vs Firstsource Solutions Ltd (3 yr)

    In the last 3 years, Firstsource Solutions Ltd has given 247.6% return, outperforming this stock by 256.0%

Replimune Group Technicals Summary

Sell

Neutral

Buy

Replimune Group is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Replimune Group Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Replimune Group Inc logo
73.19%
-59.3%
-46.65%
-71.32%
-77.35%

About Replimune Group Inc

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company's proprietary oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF for a range of solid tumors. The company is also developing RP2 that express an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3, which express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.
Organization
Replimune Group
Employees
479
CEO
Dr. Sushil Patel Ph.D.
Industry
Health Technology

Key Management of Replimune Group Inc

NameTitle
Dr. Sushil Patel Ph.D.
CEO & Director
Ms. Emily Luisa Hill
Chief Financial Officer
Dr. Konstantinos Xynos M.B.A., M.D., Ph.D.
Chief Medical Officer
Mr. Philip Astley-Sparke F.S.A.
Executive Chairman
Mr. Andrew Schwendenman
Chief Accounting Officer & Treasurer
Mr. Shawn Glidden J.D.
Senior VP & General Counsel
Mr. Camilo Garcia M.A., M.B.A.
Chief Human Resource Officer
Mr. Christopher Sarchi
Chief Commercial Officer
Mr. Paul Bullock
Chief Manufacturing Officer & Framingham Site Head
Ms. Nina Aragam
Senior Vice President of Portfolio Strategy & Program Management

Important FAQs about investing in REPL Stock from India :

What is Replimune Group share price today?

Replimune Group share price today is $5.59 as on . Replimune Group share today touched a day high of $5.66 and a low of $5.46.

What is the 52 week high and 52 week low for Replimune Group share?

Replimune Group share touched a 52 week high of $17.00 and a 52 week low of $2.68. Replimune Group stock price today i.e. is trending at $5.59, lower by 67.12% versus the 52 week high.

How to invest in Replimune Group Stock (REPL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Replimune Group on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Replimune Group Shares that will get you 0.2683 shares as per Replimune Group share price of $5.59 per share as on August 27, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Replimune Group Stock (REPL) from India?

Indian investors can start investing in Replimune Group (REPL) shares with as little as ₹87.639 or $1 (as of August 26, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹876.39 in Replimune Group stock (as per the Rupee-Dollar exchange rate as on August 26, 2025). Based on Replimune Group share’s latest price of $5.59 as on August 27, 2025 at 1:29 AM IST, you will get 1.7889 shares of Replimune Group. Learn more about fractional shares .

What are the returns that Replimune Group has given to Indian investors in the last 5 years?

Replimune Group stock has given -77.35% share price returns and 18.59% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?